Cargando…

1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility

BACKGROUND: Respiratory cultures can take up to five days to grow, time that can be crucial in treating patients with serious infections. Newer rapid microbiological identification tests are designed to shorten this delay between specimen collection and test result. The BioFire(®) FilmArray(®) Pneum...

Descripción completa

Detalles Bibliográficos
Autores principales: Strength, Rachel, Bennett, Jessica, Patel, Jay, Bowden, Jarred, Eason, Jane V, Thomas-Gosain, Neena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643760/
http://dx.doi.org/10.1093/ofid/ofab466.1214
_version_ 1784609927178747904
author Strength, Rachel
Bennett, Jessica
Patel, Jay
Bowden, Jarred
Eason, Jane V
Thomas-Gosain, Neena
author_facet Strength, Rachel
Bennett, Jessica
Patel, Jay
Bowden, Jarred
Eason, Jane V
Thomas-Gosain, Neena
author_sort Strength, Rachel
collection PubMed
description BACKGROUND: Respiratory cultures can take up to five days to grow, time that can be crucial in treating patients with serious infections. Newer rapid microbiological identification tests are designed to shorten this delay between specimen collection and test result. The BioFire(®) FilmArray(®) Pneumonia Panel is a multiplex PCR panel that can identify 8 viral, 18 bacterial, and 7 resistance gene targets in one hour. In this study, we aimed to calculate the predictive value of this test and its utility in the clinical setting. METHODS: This retrospective study compared BioFire® FilmArray® Pneumonia Panel results to respiratory cultures run at our center from 3/1/2020 to 2/28/2021. For every BioFire sample, a respiratory culture was run concurrently. We examined correlations between these two tests using data collected from the microbiology laboratory and the electronic medical record. RESULTS: 190 BioFire samples from 124 patients were submitted for processing. Of these, 148 samples had a concomitant respiratory culture result that grew organisms that BioFire could detect. BioFire and culture results were compared, and sensitivity and specificity were calculated on a per-sample basis. Sensitivity was calculated at 91%, specificity at 67%, positive predictive value at 46%, and negative predictive value at 96%. BioFire detected 30 resistance genes total, including mecA/C and MREJ, CTX-M, and KPC. The sensitivity and negative predictive value for BioFire resistance gene detection was 100%. However, specificity was 94-98%, and the positive predictive value ranged between 25-41% when compared to culture. CONCLUSION: Despite the promise of faster results and better screening, our data suggests that further study is needed to determine the utility of the BioFire pneumonia panel. The strength of the panel appears to lie in its negative predictive value and sensitivity, but as a positive predictive tool, it is suboptimal. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8643760
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86437602021-12-06 1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility Strength, Rachel Bennett, Jessica Patel, Jay Bowden, Jarred Eason, Jane V Thomas-Gosain, Neena Open Forum Infect Dis Poster Abstracts BACKGROUND: Respiratory cultures can take up to five days to grow, time that can be crucial in treating patients with serious infections. Newer rapid microbiological identification tests are designed to shorten this delay between specimen collection and test result. The BioFire(®) FilmArray(®) Pneumonia Panel is a multiplex PCR panel that can identify 8 viral, 18 bacterial, and 7 resistance gene targets in one hour. In this study, we aimed to calculate the predictive value of this test and its utility in the clinical setting. METHODS: This retrospective study compared BioFire® FilmArray® Pneumonia Panel results to respiratory cultures run at our center from 3/1/2020 to 2/28/2021. For every BioFire sample, a respiratory culture was run concurrently. We examined correlations between these two tests using data collected from the microbiology laboratory and the electronic medical record. RESULTS: 190 BioFire samples from 124 patients were submitted for processing. Of these, 148 samples had a concomitant respiratory culture result that grew organisms that BioFire could detect. BioFire and culture results were compared, and sensitivity and specificity were calculated on a per-sample basis. Sensitivity was calculated at 91%, specificity at 67%, positive predictive value at 46%, and negative predictive value at 96%. BioFire detected 30 resistance genes total, including mecA/C and MREJ, CTX-M, and KPC. The sensitivity and negative predictive value for BioFire resistance gene detection was 100%. However, specificity was 94-98%, and the positive predictive value ranged between 25-41% when compared to culture. CONCLUSION: Despite the promise of faster results and better screening, our data suggests that further study is needed to determine the utility of the BioFire pneumonia panel. The strength of the panel appears to lie in its negative predictive value and sensitivity, but as a positive predictive tool, it is suboptimal. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8643760/ http://dx.doi.org/10.1093/ofid/ofab466.1214 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Strength, Rachel
Bennett, Jessica
Patel, Jay
Bowden, Jarred
Eason, Jane V
Thomas-Gosain, Neena
1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
title 1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
title_full 1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
title_fullStr 1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
title_full_unstemmed 1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
title_short 1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
title_sort 1020. biofiring on all cylinders: validation of biofire filmarray pneumonia panel and determination of optimal utility
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643760/
http://dx.doi.org/10.1093/ofid/ofab466.1214
work_keys_str_mv AT strengthrachel 1020biofiringonallcylindersvalidationofbiofirefilmarraypneumoniapanelanddeterminationofoptimalutility
AT bennettjessica 1020biofiringonallcylindersvalidationofbiofirefilmarraypneumoniapanelanddeterminationofoptimalutility
AT pateljay 1020biofiringonallcylindersvalidationofbiofirefilmarraypneumoniapanelanddeterminationofoptimalutility
AT bowdenjarred 1020biofiringonallcylindersvalidationofbiofirefilmarraypneumoniapanelanddeterminationofoptimalutility
AT easonjanev 1020biofiringonallcylindersvalidationofbiofirefilmarraypneumoniapanelanddeterminationofoptimalutility
AT thomasgosainneena 1020biofiringonallcylindersvalidationofbiofirefilmarraypneumoniapanelanddeterminationofoptimalutility